Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
BMC Cancer|April 5, 2022
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practiceTakaya Yamamoto, Yoko Tsukita, Yu Katagiri, et al.Journal of Radiation Research|September 1, 2021
Clinical predictors of severe late urinary toxicity after curative intensity-modulated radiation therapy for localized prostate cancerKen Takeda, Rei Umezawa, Yojiro Ishikawa, et al.Advances in Radiation Oncology|December 11, 2020
Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging StudyRei Umezawa, Noriyuki Kadoya, Hideki Ota, et al.Cureus|November 23, 2022
Proton Beam Therapy With Space-Making Surgery (Omental Plombage) for Oligorecurrent Liver Metastasis of Esophageal AdenocarcinomaYojiro Ishikawa, Koji Morita, Hisashi Yamaguchi, et al.Radiation Oncology (London, England)|May 28, 2016
Renal atrophy after stereotactic body radiotherapy for renal cell carcinomaTakaya Yamamoto, Noriyuki Kadoya, Ken Takeda, et al.BMC Cancer|October 29, 2015
Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocolsRei Umezawa, Keiichi Jingu, Haruo Matsushita, et al.Clinical Lung Cancer|June 29, 2017
Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT ImagesTakaya Yamamoto, Noriyuki Kadoya, Yoshinao Sato, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 18, 2023
Safety of hydrogel spacers for rectal wall protection in patients with prostate cancer: A retrospective analysis of 200 consecutive casesHisashi Yamaguchi, Takahiro Kato, Yojiro Ishikawa, et al.Internal Medicine (Tokyo, Japan)|November 18, 2016
Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid CarcinomaKazuya Takeda, Haruo Matsushita, Masaki Kubozono, et al.Radiation Oncology (London, England)|January 16, 2014
Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinomaChiyoko Makita, Tatsuya Nakamura, Akinori Takada, et al.Pageof 8